NSE filing, NSE: HEROMOTOCO. Summary written from the filing by ALFA Finder's alert engine.
Hero MotoCorp Ltd: key numbers
- Share price
- ₹5,322.50
- Market cap
- ₹1,06,525 Cr
- Revenue (annual)
- ₹47,411 Cr
- Net profit (annual)
- ₹5,742 Cr
- P/E (TTM)
- 17.8×Sector 30.9×
- Promoter holding
- 34.72%-0.01% QoQ
- FII holding
- 32.22%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Hero MotoCorp Ltd
All →Hero MotoCorp Business Update
Hero MotoCorp updated its code of practices for fair disclosure of unpublished price-sensitive information, effective 28 October 2026. The revised code governs disclosure, spokespersons and analyst interactions.
Hero MotoCorp Investor Presentation: Key Takeaways
Q2 FY27 revenue ₹14,687 Cr (+21% YoY), PAT ₹1,456 Cr (+5%), EBITDA margin 13.4%. Growth driven by volume, mix and pricing; scooter and EV momentum continues.
Hero MotoCorp Capital Structure Change
Hero MotoCorp's board approved up to ₹300 Crore additional investment in wholly-owned subsidiary HMCL Netherlands B.V., in tranches over two years. Quarterly results were also approved.
- Value
- ₹300.0 Cr
- Execution
- 2 years, in one or more tranches
Hero MotoCorp Financial Results
Hero MotoCorp reported Q2 FY'27 consolidated revenue of Rs 14,971 Crore and PAT of Rs 1,861 Crore. It also approved up to Rs 300 Crore additional investment in a subsidiary.
Hero MotoCorp Q2 FY27 Results: Net Profit ₹1,860 Cr, Up 40.8% YoY
Hero MotoCorp Ltd reported revenue from operations of ₹14,970 Cr (+22.5% YoY) and net profit of ₹1,860 Cr (+40.8% YoY) for Q2 FY27.
- Key figure
- Net profit ₹1,860 Cr · +40.8% YoY
Hero MotoCorp Employee Stock Options
Hero MotoCorp allotted 20,615 equity shares to employees exercising options under its 2014 scheme. It also granted 281 RSUs and 842 PRSUs at face value.
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date